Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN

Supernus Pharmaceuticals (SUPN) Similar Stocks

473 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Supernus Pharmaceuticals
$1.57B
-100.67
-2.38%
2 Buy
1 Hold
0 Sell
Moderate Buy
$40.67
Alkermes
$3.99B
9.30
-17.09%
7 Buy
5 Hold
0 Sell
Moderate Buy
$35.67
Arvinas Holding Company
$1.98B
-4.87
21.83%
13 Buy
2 Hold
0 Sell
Strong Buy
$65.29
PTC Therapeutics
$2.55B
-4.33
-13.96%
5 Buy
6 Hold
3 Sell
Hold
$39.80
BioMarin Pharmaceutical
$16.14B
79.57
-1.90%
13 Buy
7 Hold
0 Sell
Moderate Buy
$106.56

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
SUPN
Supernus Pharmaceuticals
28.73
-1.40
-4.65%
ALKS
Alkermes
23.37
-4.78
-16.98%
ARVN
Arvinas Holding Company
29.97
8.05
36.72%
PTCT
PTC Therapeutics
33.13
-5.61
-14.48%
BMRN
BioMarin Pharmaceutical
84.59
-1.97
-2.28%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis